Gladstone Investment Co. (GAIN) To Go Ex-Dividend on July 19th

Share on StockTwits

Gladstone Investment Co. (NASDAQ:GAIN) declared a monthly dividend on Tuesday, July 9th, Zacks reports. Stockholders of record on Monday, July 22nd will be paid a dividend of 0.068 per share by the investment management company on Wednesday, July 31st. This represents a $0.82 annualized dividend and a dividend yield of 7.13%. The ex-dividend date of this dividend is Friday, July 19th.

Gladstone Investment has raised its dividend by an average of 2.6% annually over the last three years and has raised its dividend every year for the last 6 years. Gladstone Investment has a dividend payout ratio of 107.9% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Analysts expect Gladstone Investment to earn $0.81 per share next year, which means the company may not be able to cover its $0.82 annual dividend with an expected future payout ratio of 101.2%.

Shares of NASDAQ GAIN opened at $11.44 on Wednesday. The business’s 50 day simple moving average is $11.37. The firm has a market capitalization of $373.85 million, a P/E ratio of 14.86 and a beta of 0.85. Gladstone Investment has a 12-month low of $8.70 and a 12-month high of $12.70.

Gladstone Investment (NASDAQ:GAIN) last released its earnings results on Monday, May 13th. The investment management company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.03. The firm had revenue of $16.10 million during the quarter, compared to the consensus estimate of $13.93 million. Gladstone Investment had a return on equity of 6.37% and a net margin of 136.75%. As a group, analysts forecast that Gladstone Investment will post 0.81 earnings per share for the current year.

GAIN has been the subject of a number of research analyst reports. ValuEngine upgraded Xylem from a “hold” rating to a “buy” rating in a research report on Friday, June 21st. LADENBURG THALM/SH SH restated a “buy” rating and issued a $1.25 target price on shares of Arch Therapeutics in a research report on Wednesday, May 15th. Zacks Investment Research upgraded Golub Capital BDC from a “hold” rating to a “buy” rating and set a $20.00 target price for the company in a research report on Tuesday. Finally, BidaskClub downgraded ZIX from a “buy” rating to a “hold” rating in a research report on Wednesday.

Gladstone Investment Company Profile

Gladstone Investment Corporation is a private equity fund specializing in lower middle market, acquisitions, mature stage, buyouts; recapitalizations; refinancing existing debt; senior debt securities such as senior loans, senior term loans, lines of credit, and senior notes; senior subordinated debt securities such as senior subordinated loans and senior subordinated notes; junior subordinated debt securities such as subordinated notes and mezzanine loans; limited liability company interests, and warrants or options.

Further Reading: What are the qualifications of a portfolio manager?

Dividend History for Gladstone Investment (NASDAQ:GAIN)

Receive News & Ratings for Gladstone Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gladstone Investment and related companies with MarketBeat.com's FREE daily email newsletter.